Predictors of arm morbidity following breast cancer surgery

Psycho-Oncology

Volumn 19, Issue 11, 2010, Pages 1205-1212

  Hack, Thomas F ^a   Kwan, Winkle B ^b   Thomas Maclean, Roanne L ^c   Towers, Anna ^d   Miedema, Baukje ^e   Tilley, Andrea ^f   Chateau, Dan ^g  

^a UNIVERSITY OF MANITOBA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f Atlantic Health Science Corporation   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

arm morbidity; axillary; breast cancer; lymphedema; sentinel node

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ADVANCED CANCER; ARM DISEASE; ARM EDEMA; ARM MOVEMENT; ARTICLE; AXILLARY LYMPH NODE; BEHAVIOR THERAPY; BODY MASS; BREAST CANCER; CANADA; CANCER CENTER; CANCER STAGING; CANCER SURGERY; CLINICAL ASSESSMENT; DEMOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH PROGRAM; HUMAN; LYMPH NODE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; PATIENT EDUCATION; POSTOPERATIVE INFECTION; RANGE OF MOTION; SOCIAL PSYCHOLOGY; SYMPTOM;

ADULT; AGED; ARM; AXILLA; BREAST NEOPLASMS; CANADA; COHORT STUDIES; FEMALE; HUMANS; LYMPHEDEMA; MASTECTOMY; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; PAIN MEASUREMENT; POSTOPERATIVE COMPLICATIONS; PSYCHOMETRICS; QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; SENTINEL LYMPH NODE BIOPSY;

EID: 78349284833     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1685     Document Type: Article

References (41)

1. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR,. Lymphedema and quality of life in breast cancer survivors: The Iowa Women's Health Study. J Clin Oncol 2008; 26: 5689-5696.
2. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK,. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology 2004; 37: 73-91.
3. Goyal A, Newcombe RG, Chhabra A, Mansel RE,. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Ann Surg Oncol 2008; 15: 262-267.
4. Hack TF, Cohen L, Katz J, Robson LS, Goss P,. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999; 17: 143-149.
5. Langer I, Guller U, Berclaz G, et al,. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 2007; 245: 452-461.
6. Mansel RE, Fallowfield L, Kissin M, et al,. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 2006; 98: 599-609.
7. Purushotham AD, Upponi S, Klevesath MB, et al,. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 2005; 23: 4312-4321.
8. Rietman JS, Dijkstra PU, Geertzen JHB, et al,. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast carcinoma. Cancer 2003; 98: 690-696.
9. Thomas-MacLean RL, Hack T, Kwan W, Towers A, Miedema B, Tilley A,. Oncol Nurs Forum 2008; 35: 65-71.
10. Wilke LG, McCall LM, Posther KE, et al,. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006; 13: 491-500.
11. Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA,. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002; 20: 4242-4248.
12. Reitman JS, Geertzen JH, Hoekstra HJ, et al,. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II cancer. Eur J Surg Oncol 2006; 32: 148-152.
13. Scalfani LM, Baron RH,. Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction. Cancer J 2008; 14: 216-222.
14. Erickson VS, Pearson ML, Ganz PA,. Arm edema in breast cancer patients. J Natl Cancer Inst 2001; 93: 96-111.
15. Pyszel A, Malyszczak K, Pyszel K, Andrzejak R, Szuba A,. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 2006; 39: 185-192.
16. Ridner SH,. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer 2005; 13: 904-911.
17. Chachaj A, Malyszczak K, Pyszel K, et al,. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psycho-Oncology 2009; E-pub ahead of print. DOI: 10.1002/pon.1573.
18. Oliveri JM, Day JM, Alfano CM, et al,. Arm/hand swelling and perceived functioning among breast cancer survivors 12 years post-diagnosis: CALGB 79804. J Cancer Surviv 2008; 2: 233-242.
19. Samphao S, Eremin JM, El-Sheemy M, Eremin O,. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach. Ann Surg Oncol 2008; 15: 1282-1296.
20. Posther KE, McCall LM, Blumencranz PW, et al,. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg 2005; 242: 593-602.
21. Marcks P,. Lymphedema: pathogenesis, prevention, and treatment. Cancer Pract 1997; 5: 32-38.
22. Melzack R,. The McGill pain questionnaire: major properties and scoring methods. Pain 1975; 1: 277-299.
23. Armer J, Fu MR,. Age differences in post-breast cancer lymphedema signs and symptoms. Cancer Nurs 2005; 28: 200-207.
24. Hayes S, Cornish B, Newman B,. Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat 2005; 94: 1-10.
25. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology 2003; 36: 84-91.
26. Karges JR, Mark BE, Strikeleather SJ, Worrell TW,. Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther 2003; 83: 134-145.
27. Kligman L, Wong RK, Johnston M, Laetsch NS, Members of the Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care. The treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Suppor Care Cancer 2004; 12: 421-431.
28. McNeely ML, Magee DJ, Lees AW, Bagnall KM, Haykowsky M, Hanson J,. The addition of manual lymph drainage to compression therapy for breast cancer related lymphedema: a randomized controlled trial. Breast Cancer Res Treat 2004; 86: 95-106.
29. Sagen A, Kåresen R, Risberg MA,. The reliability of a simplified water replacement instrument: a method for measuring arm volume. Arch Phys Med Rehabil 2005; 86: 86-89.
30. Beaton DE, Davis AM, Hudak PL, McConnell S,. The DASH (Disabilities of the Arm, Shoulder and Hand) outcome measure: what do we know about it now? Br J Hand Ther 2001; 6: 109-118.
31. Gummesson C, Atroshi I, Ekdahl C,. The Disabilities of the Arm, Shoulder, and Hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-related health change after surgery. BMC Musculoskelet Disord 2004; 4: 11.
32. Hummel TJ, Sligo J,. An empirical comparison of univariate and multivariate analysis of variance procedures. Psych Bull 1971; 76: 49-57.
33. Goffman TE, Laronga C, Wilson L, Elkins D,. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J 2004; 10: 405-411.
34. Reitman JS, Dijkstra PU, Geertzen JH, et al,. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 2004; 11: 1018-1024.
35. Thomas-Maclean RL, Hack T, Kwan W, Towers A, Miedema B, Tilley A,. Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum 2008; 35: 65-71.
36. Quan ML, Hodgson N, Lovrics P, Porter G, Poirier B, Wright FC,. National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience. Breast J 2008; 14: 421-427.
37. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B,. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 2008; 26: 3536-3542.
38. Rockson SG,. Precipitating factors in lymphedema: myths and realities. Cancer 1998; 83: 2814-2816.
39. Soran A, D'Angelo G, Bergovic M, et al,. Breast cancer-related lymphedema-What are the significant predictors and how do they affect the severity of lymphedema? Breast J 2006; 12: 536-543.
40. Van der Veen P, De Voogdt N, Lievens P, Duquet W, Lamote J, Sacre R,. Lymphedema development following breast cancer surgery with full axillary resection. Lymphology 2004; 37: 206-208.
41. Meeske KA, Sullivan-Halley J, Smith AW,. Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat 2009; 113: 383-391.